Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shang-Ke-Huang-Shui is a traditional Chinese medicine (TCM) topical liquid preparation developed as an in-hospital formula by the Foshan Hospital of Traditional Chinese Medicine. It is widely used in Southern China for the treatment of traumatic injuries, skin infections, and chronic non-healing wounds, including diabetic foot ulcers (DFU). The formulation is derived from several classical 'heat-clearing and detoxifying' herbs, typically including *Coptis chinensis* (Huang Lian), *Phellodendron amurense* (Huang Bai), *Scutellaria baicalensis* (Huang Qin), *Gardenia jasminoides* (Zhi Zi), and *Rheum palmatum* (Da Huang). Pharmacologically, it exhibits potent anti-inflammatory, antimicrobial, and analgesic properties. It is thought to promote wound healing by modulating the local inflammatory microenvironment, reducing exudation, and enhancing tissue regeneration and microcirculation at the site of application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shang-Ke-Huang-Shui.